4. Add an additional 20 l of 0.1 M imidazole, pH 6.0. Mix and react for at least 2 hours
at room temperature. The additional buffer prevents pH drift during the carbodiimide
reaction.
5. Purify the hydrazide-labeled oligo by gel fi ltration on a desalting resin using 10 mM
sodium phosphate, 0.15 M NaCl, 10 mM EDTA, pH 7.2. The hydrazide-containing probe
now may be used to conjugate with a molecule containing an aldehyde-reactive group.
4.6. Introduction of Saccharide or Glycan Groups
The modifi cation of proteins with sugar groups occurs in vivo through both enzymatic and non-
enzymatic processes. Approximately 1 percent of proteins encoded in the genomes of mammals
are enzymes that are involved with carbohydrate production or modifi cation. Many of these
enzymes digest carbohydrate in foods to provide energy for cellular metabolism, but others
are involved with the controlled modifi cation of proteins or other biomolecules to create com-
plex polysaccharide structures. This process results in carbohydrates, called glycans, covalently
attached to proteins at discrete locations on only certain amino acid residues within a polypep-
tide sequence (Section 2, this chapter). The presence of carbohydrate modifi cations on proteins
has a pronounced effect on biological activity in vivo .
Non-enzymatic modifi cation of proteins with saccharides also occurs in vivo through uncon-
trolled glycation of lysine amines with the reducing end of sugars, especially glucose. This reac-
tion results in the formation of an initial Schiff base with a subsequent rearrangement to form
a stable ketoamine derivative. The non-enzymatic glycation reaction has been studied exten-
sively as a result of it being a major factor in the development of the complications associated
with diabetes (for review, see Singh et al ., 2001).
In vitro modifi cation of protein can be done synthetically to add specifi c sugars or com-
plex carbohydrates to proteins for further bioconjugation or for subsequent study of the
glycan-derivative in vivo. Investigations of the effect of these synthetic carbohydrate–protein
conjugates (neoglycoproteins) on the immune response date back many decades with the dia-
zonium-mediated coupling of aminophenol glucosides to study type-II and type-III pneumonia
polysaccharides (Goebel et al., 1932). More recently, conjugation of carbohydrates to pro-
tein carriers has been done to illicit a specifi c immune response to glyco-antigens of infectious
diseases or tumor cells (Toyokuni and Singhal, 1995; Koganty et al., 1996; Ragupathi et al .,
1997; Pozsgay, 1998; Mawas et al., 2002; Karsten et al., 2004). Synthetic peptide–glycan con-
jugates also have been prepared by conjugation of carbohydrates to peptide sequences that can
be presented by MHC (major histocompatibility complex) molecules to enhance the immune
response against the carbohydrate component (Kihlberg and Magnusson, 1996). For an excel-
lent review of glycoconjugation, see Davis (1999).
Sugar residues also can be used to modify a protein, molecule, or surface for subsequent use
in a bioconjugation procedure or to increase the hydrophilicity of the modifi ed molecule. For
bioconjugation purposes, a sugar group can be added to facilitate the covalent conjugation of
another molecule. Since many saccharides contain diols that can be oxidized by periodate to cre-
ate aldehydes, certain sugars can be used after glycol oxidation to couple with amine-contain-
ing molecules by reductive amination. For instance, the amine group on the monosaccharide
glucosamine can be coupled to an amine-reactive surface or to a protein through its carboxy-
late groups using EDC (Chapter 3, Section 1.1). The glucosamine-modifi ed surface or molecule
4. Creating Specifi c Functionalities 147